title: [The new mucosal adjuvant Cry1Ac increase the capacity of mononuclear cells to stop bacterial growth].
authors.forename: Alain R
authors.initials: AR
authors.lastname: Rodríguez-Orozco
authors.forename: Francisco
authors.initials: F
authors.lastname: Ayala-Mata
authors.forename: Rebeca
authors.initials: R
authors.lastname: Tinoco-Martínez
authors.forename: Lorena
authors.initials: L
authors.lastname: Cabrera-Navarro
mesh_terms: D000583:Amikacin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins / Q000494:pharmacology*; D001427:Bacterial Toxins / Q000494:pharmacology*; D002478:Cells, Cultured / Q000187:drug effects / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004731:Endotoxins / Q000494:pharmacology*; D006460:Hemolysin Proteins / Q000494:pharmacology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000276:immunology; D050296:Microbial Viability / Q000187:drug effects / Q000276:immunology*; D011513:Proteus mirabilis / Q000187:drug effects / Q000254:growth & development; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D011994:Recombinant Proteins / Q000494:pharmacology; D012475:Salmonella / Q000187:drug effects / Q000254:growth & development; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development
chemical_list: D000900:Anti-Bacterial Agents; D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004731:Endotoxins; D006460:Hemolysin Proteins; D011994:Recombinant Proteins; C030956:insecticidal crystal protein, Bacillus Thuringiensis; D003208:Concanavalin A; D000583:Amikacin